2-({2-[2-(3,5-dimethyl-1H-pyrazol-4-yl)ethyl]-[1,2,4]triazolo[1,5-c]quinazolin-5-yl}sulfanyl)-N-(3-fluoro-4-methylphenyl)acetamide

InChIKey	`QAJFPPXXVZWNQN-UHFFFAOYSA-N`
Compound Name	2-({2-[2-(3,5-dimethyl-1H-pyrazol-4-yl)ethyl]-[1,2,4]triazolo[1,5-c]quinazolin-5-yl}sulfanyl)-N-(3-fluoro-4-methylphenyl)acetamide
Canonical SMILES	`Cc1ccc(NC(=O)CSc2nc3ccccc3c3nc(CCc4c(C)n[nH]c4C)nn23)cc1F`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	3
Pfam Stratification	Cross-Family
Avg pChEMBL	6.41
Source	ChEMBL;BindingDB

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P37231	PPARG	Homo sapiens	Human	PF00104 PF12577 PF00105	6.5	IC50	ChEMBL
Q9Y618	NCOR2	Homo sapiens	Human	PF15784 PF00249	6.5	IC50	ChEMBL;BindingDB
Q9Y5X4	NR2E3	Homo sapiens	Human	PF00104 PF00105	6.3	IC50	ChEMBL;BindingDB